
September 19, 2022
BRC Investigators Publish Results of Randomized Trial of Anti-Fibrinolytic Therapy and Ancillary Laboratory Study in ‘Blood’ and ‘Blood Advances’
In the NIH-funded ‘American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)’ trial, UNC was one of 3 participating clinical centers to enroll patients with platelet transfusion-dependence due to therapy for hematologic malignancies. Between 2016 and 2020, 337 patients were randomized in a double blind fashion to tranexamic acid (TXA) or placebo. Ultimately, no benefit of …